Company Filing History:
Years Active: 2013
Title: Gerrit Jansen: Innovator in Pharmaceutical Chemistry
Introduction
Gerrit Jansen is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for medical treatments. His work focuses on innovative solutions for serious health conditions.
Latest Patents
Gerrit Jansen holds a patent for "Cyclopenta{G}quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia." This patent describes a cyclopenta[g]quinazoline derivative that contains an L-Glu-γ-D-Glu dipeptide group. The compound is designed to be effective in treating rheumatoid arthritis or acute myeloid leukaemia, showcasing his commitment to advancing medical science.
Career Highlights
Jansen is associated with Btg International Limited, where he applies his expertise in pharmaceutical development. His work has led to the creation of innovative compounds that have the potential to improve patient outcomes in various medical conditions.
Collaborations
Gerrit collaborates with Ann Lesley Jackman, contributing to the advancement of their shared goals in pharmaceutical research. Their partnership exemplifies the importance of teamwork in the innovation process.
Conclusion
Gerrit Jansen's contributions to pharmaceutical chemistry highlight his role as an inventor dedicated to improving healthcare through innovative solutions. His patent work and collaborations reflect a commitment to addressing critical medical challenges.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.